Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa

BOSTON, October 02, 2023--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Abbey Jenkins, President and Chief Executive Officer, will present its corporate highlights at the annual Cell & Gene Meeting on the Mesa to be held October 10-12 in Carlsbad, California, and livestreamed globally. Ms. Jenkins will also participate in a panel titled "A record setting year for cell and gene therapies – how do we keep the momentum

Related Keywords

California ,United States ,Boston ,Massachusetts ,Chuck Padala ,Savannah Bryant ,Abbey Jenkins ,Dan Boyle ,Exchange Commission ,Gamida Cell Ltd ,Nasdaq ,Alliance For Regenerative Medicine ,Gamida Cell Inc ,Chief Executive Officer ,Gamida Cell ,Gene Meeting ,Regenerative Medicine ,Aseptic Technologies Ballroom ,Park Hyatt Aviara Resort ,Stephen Majors ,Safety Information ,Host Disease ,Prescribing Information ,Serious Infections ,Quality Assurance ,Rare Genetic ,Private Securities Litigation Reform Act ,Risk Factors ,Quarterly Report ,Cord Blood ,Gene Therapies ,Ngraftment Syndrome ,Cell Therapy ,Infusion ,Fell ,Aviara Resort ,Immunosuppressive Therapy ,